NumFin

BIOLASE, Inc.

Sümbol: BIOL

NASDAQ

0.1739

USD

Turuhind täna

  • -0.0255

    P/E suhe

  • -0.0015

    PEG suhe

  • 5.78M

    MRK Cap

  • 0.00%

    DIV tootlus

BIOLASE, Inc. (BIOL) Finantsaruanded

Download
AastaneQuarterly
LineaarneLog
Diagrammil näete BIOLASE, Inc. (BIOL) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

AastaneQuarterly
10Y20Y30Y40Y

Bilanss

Sukeldudes BIOLASE, Inc. fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995199419931992

balance-sheet.row.cash-and-short-term-investments

06.64.230
17.6
5.8
8
11.6
8.9
11.7
31.6
1.4
2.5
3.3
1.7
3
11.2
14.6
14.7
18.1
31.5
11.1
3.9
2.7
2
1.2
0.4
0.2
0.3
1.6
1.2
2
1.3

balance-sheet.row.short-term-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
9.9
25.3
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

05.55.84.2
3.1
8.8
11.1
10.1
9.8
8.9
9
11.1
11.7
8.9
3.3
4.2
3.8
11.3
15.2
8.4
9.6
5.8
4.8
2.1
0.8
0.3
0.6
1.1
0.1
0.1
0.1
0.2
1.2

balance-sheet.row.inventory

011.415.912.9
11.2
11
12.2
12.3
13.5
12.6
12.5
11.4
11.1
11.3
7
7.9
12.4
7.6
7.8
8.6
8.2
3.8
2.8
1.9
1.2
0.7
1.9
1
0.4
0.4
0.6
0.6
1.1

balance-sheet.row.other-current-assets

01.43.12
3
1.2
1.6
1.7
1.5
1.4
1.7
1.9
1.6
1.8
0.6
1.3
1.4
2.3
1.3
1.3
1.8
0.1
1
0.3
0.2
0.1
0.4
0.7
3.6
0.1
0
0.1
0.1

balance-sheet.row.total-current-assets

024.92949.4
35.1
27
33.3
36
34
34.8
54.8
25.9
26.9
25.3
13.9
16.4
28.8
35.8
39
36.5
51.1
23.3
12.6
6.9
4.2
2.3
3.3
3
4.4
2.2
1.9
2.9
3.7

balance-sheet.row.property-plant-equipment-net

0762.8
2.8
1.5
2
3.7
4.5
3.7
1.3
1.8
1.5
1.1
0.8
2.2
3
4
4.9
3.8
3
2
1.7
0.4
2.3
0.2
0.4
0.2
0.2
0.3
0.4
0.9
1.1

balance-sheet.row.goodwill

02.92.92.9
2.9
2.9
2.9
2.9
2.9
2.9
2.9
2.9
2.9
2.9
2.9
2.9
2.9
2.9
2.9
2.9
2926
2926
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.intangible-assets

0000
0
0
0
0
0
0.1
0.1
0.2
0.3
0.2
0.3
0.5
0.6
1.2
1.5
4.8
4.6
5.5
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
1.1
0.6

balance-sheet.row.goodwill-and-intangible-assets

02.92.92.9
2.9
2.9
2.9
2.9
2.9
3
3
3.1
3.2
3.1
3.3
3.4
3.5
4.1
4.4
4.8
4.6
5.5
0.1
0.1
0.1
0.1
0.1
0.1
0
0
0
1.1
0.6

balance-sheet.row.long-term-investments

0000
0
-0.1
-0.1
-0.1
-0.8
-0.7
-0.7
-0.6
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

0000
0
0.1
0.1
0.1
0.8
0.7
0.7
0.6
0
0
0
0
0
0.1
0
0
0
12.7
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-non-current-assets

00.30.30.2
0.2
0.4
0.3
0.3
0.6
0.7
0.3
0.2
0.3
0.2
0.2
0.2
0.3
0.3
0.3
0.1
0
1
0
0.2
0
0.1
0.1
0.1
0.1
0
0.1
0.2
0.2

balance-sheet.row.total-non-current-assets

010.29.25.9
5.9
4.8
5.2
6.9
8
7.5
4.6
5.2
5.1
4.5
4.2
5.8
6.9
8.5
9.6
8.7
7.7
21.2
1.8
0.6
2.4
0.4
0.6
0.4
0.3
0.3
0.5
2.2
1.9

balance-sheet.row.other-assets

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

035.138.255.3
41
31.8
38.5
43
41.9
42.3
59.4
31
32
29.8
18.1
22.2
35.7
44.3
48.6
45.1
58.7
44.5
14.4
7.6
6.6
2.7
3.9
3.4
4.7
2.5
2.4
5.1
5.6

balance-sheet.row.account-payables

06.15.83.3
2.7
5.3
6
5.1
9.1
6
8.4
8.6
7.7
7.8
4
4.9
7.5
6.2
7.7
5
7.1
3.6
2.1
1.7
0.9
0.8
0.8
0.5
0.1
0
0.1
0.3
1.2

balance-sheet.row.short-term-debt

03.20.70.4
0.3
13.5
0
0
0.2
0.2
0
4.6
1.6
2.6
2.6
0
5.4
3.6
0
5
11.5
2.7
3
1.8
1.8
1.3
1.7
0.3
0
0
0
0.5
0.3

balance-sheet.row.tax-payables

00.50.40.6
0.2
0.2
0.7
0.5
0.6
0.4
0.1
0.3
0.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

01414.315.1
18
4.2
10.8
0.1
0.8
0.2
0
0
0
0
0
0
0
-2.2
-4.3
0
0
0
0
0
1.2
0
0
0
0
0
0
0
0.2

Deferred Revenue Non Current

00.30.40.3
0.4
0.4
-2.5
0
0
0.1
0
0
0
0
0.4
2
1.9
2.2
4.3
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

089.27.9
6.4
4.7
7.5
5.6
5.6
5.7
5.2
5
6.3
3.6
11.4
5.6
8.3
9.4
8.9
11.4
0.1
6.2
-325
0.4
1.6
1.5
0.7
0.5
0.7
0.7
0.6
1
1.1

balance-sheet.row.total-non-current-liabilities

015.715.516.2
19.8
5.7
11.5
0.4
1.9
2.2
1.2
0.6
0.8
1
1.5
2.6
2.5
3
4.5
0.2
3.6
0.1
0.1
0.2
1.2
2.1
2.5
0.8
0.1
0
0.1
0.6
0.2

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-2.1
-2.5
-0.8
-0.1
0
-0.1
0
0

balance-sheet.row.capital-lease-obligations

00.81.31.4
1.8
0.3
0
0
0.2
0.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

035.333.330.1
31
31.5
27.4
13.7
19.9
17.3
17.3
22.6
20.2
17.2
21.2
14.2
26.3
27.8
26.6
23.8
24.8
12.7
9.2
6
5.5
3.6
3.2
1.3
0.8
0.7
0.7
2.4
2.8

balance-sheet.row.preferred-stock

02.200
0.1
4
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0000.2
0.1
0
0
0.1
0.1
0.1
0.1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.retained-earnings

0-316.8-296.2-267.5
-251.4
-234.5
-216.7
-195.2
-178.3
-163
-142.7
-123.8
-112.3
-109.2
-104.7
-92.7
-89.7
-80.6
-73.2
-68.5
-51
-27.3
-44.3
-46.9
-46.5
-42.8
-38
-27.6
-24.8
-22.3
-20.3
-17.3
-9.7

balance-sheet.row.accumulated-other-comprehensive-income-loss

0-0.6-0.7-0.6
-0.4
-0.7
-0.7
-0.6
-0.9
-0.8
-0.6
-0.3
-0.3
-0.4
-0.3
-0.2
-0.2
0.1
0.1
-0.3
-0.2
-0.1
-0.1
-0.3
-0.2
-1.3
-1.2
-1.1
-1
-0.9
-0.8
-0.8
-0.6

balance-sheet.row.other-total-stockholders-equity

0314.9301.8293.2
261.6
231.6
228.4
224.9
201.2
188.6
185.2
132.5
124.3
122.1
102
100.8
99.3
97
95
90.1
85.2
59.2
49.5
48.8
47.8
43.1
39.9
30.8
29.7
25
22.8
20.8
13.1

balance-sheet.row.total-stockholders-equity

0-0.24.925.2
10
0.4
11.1
29.3
22.1
24.9
42.1
8.5
11.8
12.6
-3
7.9
9.4
16.5
22
21.3
34
31.8
5.2
1.6
1.1
-0.9
0.7
2.1
3.9
1.8
1.7
2.7
2.8

balance-sheet.row.total-liabilities-and-stockholders-equity

035.138.255.3
41
31.8
38.5
43
41.9
42.3
59.4
31
32
29.8
18.1
22.2
35.7
44.3
48.6
45.1
58.7
44.5
14.4
7.6
6.6
2.7
3.9
3.4
4.7
2.5
2.4
5.1
5.6

balance-sheet.row.minority-interest

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-equity

0-0.24.925.2
10
0.4
11.1
29.3
22.1
24.9
42.1
8.5
11.8
12.6
-3
7.9
9.4
16.5
22
21.3
34
31.8
5.2
1.6
1.1
-0.9
0.7
2.1
3.9
1.8
1.7
2.7
2.8

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0000
0
-0.1
-0.1
-0.1
-0.8
-0.7
-0.7
-0.6
0
0
0
0
0
0
0
9.9
25.3
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-debt

017.915.115.1
18
13.5
10.8
0
0.2
0.2
0
4.6
1.6
2.6
2.6
0
5.4
3.6
0
5
0
2.7
3
1.8
3
1.3
1.7
0.3
0
0
0
0.5
0.5

balance-sheet.row.net-debt

011.310.9-14.9
0.4
7.7
2.8
-11.6
-8.8
-11.5
-31.6
3.2
-0.9
-0.7
0.9
-3
-5.8
-11
-14.7
-3.3
-6.1
-8.4
-0.9
-0.9
1
0.2
1.3
0.1
-0.3
-1.6
-1.2
-1.5
-0.8

Rahavoogude aruanne

BIOLASE, Inc. finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995199419931992

cash-flows.row.net-income

0-20.6-28.6-16.2
-16.8
-17.9
-21.5
-16.9
-15.4
-20.3
-18.9
-11.5
-3.1
-4.5
-12
-3
-9.1
-7.3
-4.7
-17.5
-23.2
19.1
2.6
-0.4
-3.7
-4.8
-10.3
-2.8
-2.5
-2
-3.5
-7.5
-5.5

cash-flows.row.depreciation-and-amortization

02.80.50.4
0.5
1
0.9
1.2
1
0.9
0.7
0.6
0.5
0.7
1.1
1.4
1.9
1.9
2.3
1.2
0.7
0.4
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.2
0.4
0.6
0.2

cash-flows.row.deferred-income-tax

00.70-3.6
-2.1
0
0
-0.7
0.1
0.1
0.1
0
0.1
0
0.1
0.1
0.1
0.1
0
0
14.3
-11448
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

01.22.31.7
3.4
2.7
2.8
2.2
3.1
3.4
1.2
1.7
1.6
1.5
0.7
1.4
1.7
1.5
0.4
0.4
0
11448
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

01-5.10
1.8
-1.1
0
-5.4
0.5
-2.5
-1.6
-2.2
-1.8
-12.3
6.1
-3.5
0.2
0.8
-0.1
-2
5.1
-2
-2.4
-1.1
-0.7
1.7
-1.6
-1.6
0.1
0.2
-0.1
-0.2
-0.5

cash-flows.row.account-receivables

00.2-1.6-1
4.3
0.7
-1.5
-0.3
-0.6
-0.1
0.8
0.3
-3.2
-5.6
1
-0.3
7.5
-7.7
1.1
1.1
-4218
-1036
-3084
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

01-5.8-1.4
-0.9
0.8
-0.1
0.4
-2
-0.7
-1.7
-1.4
-0.2
-4.7
0.9
3.5
-4.9
0.1
0.7
-1.2
-4.8
-0.9
-0.9
-0.8
-0.9
1.2
-1
-0.8
0
0.2
-0.1
-0.1
-0.6

cash-flows.row.account-payables

0-1.93.52
-2.1
-2.7
1.8
-5
3.3
-0.6
0.5
-1
-0.3
4.3
-0.8
-5
0.9
-1.2
1.7
1.7
6136
3645
2030
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

01.7-1.20.3
0.4
0.1
-0.2
-0.5
-0.2
-1.2
-1.2
0
1.9
-6.2
5
-1.7
-3.2
9.6
-3.7
-3.7
-1908.1
-2610.1
1052.5
-0.3
0.2
0.5
-0.6
-0.8
0.1
0
0
-0.1
0.1

cash-flows.row.other-non-cash-items

00.84.11
0.5
2.5
3.7
1.1
0.1
0.8
2.3
2.1
1
1.2
0.2
1
0.7
-0.2
2.5
0.8
1.5
-11.2
0.2
0.3
0.5
1.1
7
0.3
0.1
-0.1
0.6
1.3
0.4

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-1.3-3.7-0.7
-0.1
-0.2
-0.6
-0.7
-1.4
-1.8
-0.2
-0.7
-0.8
-0.4
-0.2
-0.4
-1
-0.9
-2.3
-1.9
-1.4
-0.5
-0.5
-0.2
-1.1
-0.1
-0.3
-0.1
-0.1
0
-0.1
-0.3
-0.8

cash-flows.row.acquisitions-net

00.200
0
0
0
0
0
0
0
0
0
0
0
0
0
0
20
0
0
-1.8
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.purchases-of-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
-20
-20
-77
0
0
0
0
0
-2.5
0
-4
0
0
0
0

cash-flows.row.sales-maturities-of-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
10
10
35.3
51.8
0
0
0
0
0.3
2.9
2.9
0
0
0
0
0.4

cash-flows.row.other-investing-activites

0000
0
0
0
0
0
0
0
0
0.1
0
0
0
0
-10
0.1
0
-0.1
0
0
2.3
0
0
-0.1
-0.1
0.5
-0.1
0
0
-0.6

cash-flows.row.net-cash-used-for-investing-activites

0-1.1-3.7-0.7
-0.1
-0.2
-0.5
-0.7
-1.4
-1.8
-0.2
-0.7
-0.7
-0.4
-0.2
-0.4
-1
-0.9
7.7
13.4
-26.7
-2.3
-0.5
2.1
-1.1
0.2
0
2.7
-3.6
-0.1
-0.1
-0.3
-1

cash-flows.row.debt-repayment

0-0.2-10
-3.7
-2.4
-3.7
-0.1
-0.2
-0.1
-21.5
-32.1
-15
-2.7
-0.3
-9.7
-27.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-issued

017.65.614.4
6.9
9.2
0
21.8
9.5
0
51.1
5.2
0
17.2
0
0
0
0.7
3.1
1.2
43.1
3.6
1
0.8
5.7
2.8
3.7
0.9
4.5
2.1
2.1
6.4
7.1

cash-flows.row.common-stock-repurchased

0000
17.4
0
0
0
0
0
0
0
-0.2
-0.3
0
0
0
0
0
0
-16.4
0
0
0
0
0
0
0
0
0
0
0
-0.3

cash-flows.row.dividends-paid

00-0.2-0.5
-17.4
0
0
0
0
0
0
0
0
-1.2
0
0
0
0
-0.7
-0.7
-0.7
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

07.90.216.1
21.1
3.9
15
0
0
0
17.1
35.8
16.8
2.4
3.1
4.5
29.9
3.6
-4.3
5
-2.7
-0.5
0
-1.2
0
-0.4
1.4
0.3
0
0
-0.2
0.2
-0.3

cash-flows.row.net-cash-used-provided-by-financing-activities

017.44.630
24.3
10.7
11.2
21.6
9.3
-0.1
46.8
8.8
1.6
15.4
2.8
-5.2
2.4
4.3
-1.9
5.6
23.4
3.1
1
-0.4
5.7
2.5
5.1
1.2
4.5
2.1
1.9
6.6
6.5

cash-flows.row.effect-of-forex-changes-on-cash

00.2-0.1-0.2
0.3
0
-0.1
0.3
-0.1
-0.2
-0.2
0
0
0
0
0
-0.2
-0.2
0.2
0.2
-0.1
0
0.1
0
0
0
0
0
0
0
0
0.2
0

cash-flows.row.net-change-in-cash

02.4-2612.3
11.8
-2.3
-3.5
2.7
-2.8
-19.9
30.1
-1.1
-0.8
1.6
-1.3
-8.3
-3.3
-0.1
6.4
2.1
-5
7.2
1.3
0.7
0.8
0.8
0.3
-0.1
-1.3
0.3
-0.8
0.7
0.1

cash-flows.row.cash-at-end-of-period

06.64.230.2
17.9
6.1
8.4
11.6
8.9
11.7
31.6
1.4
2.5
3.3
1.7
3
11.2
14.6
14.7
8.3
6.1
11.1
3.9
2.7
2
1.2
0.5
0.2
0.3
1.5
1.2
2
1.3

cash-flows.row.cash-at-beginning-of-period

04.230.217.9
6.1
8.4
11.9
8.9
11.7
31.6
1.4
2.5
3.3
1.7
3
11.2
14.6
14.7
8.3
6.1
11.1
3.9
2.7
2
1.2
0.4
0.2
0.3
1.6
1.2
2
1.3
1.2

cash-flows.row.operating-cash-flow

0-14.1-26.8-16.7
-12.8
-12.7
-14.1
-18.4
-10.6
-17.8
-16.2
-9.3
-1.7
-13.3
-3.8
-2.6
-4.5
-3.3
0.4
-17.1
-1.6
6.3
0.6
-1
-3.8
-1.9
-4.8
-4
-2.2
-1.7
-2.6
-5.8
-5.4

cash-flows.row.capital-expenditure

0-1.3-3.7-0.7
-0.1
-0.2
-0.6
-0.7
-1.4
-1.8
-0.2
-0.7
-0.8
-0.4
-0.2
-0.4
-1
-0.9
-2.3
-1.9
-1.4
-0.5
-0.5
-0.2
-1.1
-0.1
-0.3
-0.1
-0.1
0
-0.1
-0.3
-0.8

cash-flows.row.free-cash-flow

0-15.4-30.5-17.4
-12.9
-13
-14.7
-19.2
-12.1
-19.6
-16.4
-10
-2.5
-13.7
-4
-3
-5.5
-4.1
-1.9
-18.9
-3
5.9
0.2
-1.2
-4.8
-2
-5.1
-4.1
-2.3
-1.7
-2.7
-6.1
-6.2

Kasumiaruande rida

BIOLASE, Inc. tulud muutusid võrreldes eelmise perioodiga NaN%. BIOL brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln

USD
Growth
TTM20232022202120202019201820172016201520142013201220112010200920082007200620052004200320022001200019991998199719961995199419931992

income-statement-row.row.total-revenue

049.248.539.2
22.8
37.8
46.2
46.9
51.8
48.5
47.7
56.4
57.4
48.9
26.2
43.3
64.6
66.9
69.7
62
60.7
49.1
29.2
17.9
9.7
7
1.5
1.8
0.7
1.2
1.1
2.4
5.5

income-statement-row.row.cost-of-revenue

032.432.622.7
16.6
23.5
29.3
31.8
31.5
32.5
29.5
34.9
30.9
27.5
17.4
23.3
32
32.4
33.2
31.2
24.6
17.5
11.1
7.3
4.7
4
1.3
1.4
0.5
0.6
0.8
2.3
3.4

income-statement-row.row.gross-profit

016.715.916.5
6.2
14.3
16.9
15.1
20.3
15.9
18.2
21.5
26.5
21.3
8.8
20.1
32.7
34.5
36.5
30.8
36
31.6
18.1
10.6
5
3
0.2
0.4
0.2
0.6
0.3
0.1
2.1

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

0000
4.2
0
0
0
-0.3
0.4
0.3
0.4
4.7
0
0
4.1
0
0.8
0.3
-0.1
7.2
-0.1
0
0
0.2
0.1
0.1
0.1
0.1
0.2
0.4
0.6
0.2

income-statement-row.row.operating-expenses

034.741.232.6
24.7
29.9
35.1
32.7
35.3
36.6
36.1
32.5
29
25.3
20.3
23
39.6
43.5
41.3
47.8
45.4
24.1
15.6
11
8.6
7.7
5.3
3.3
2.7
2.5
4.2
7.6
7.6

income-statement-row.row.cost-and-expenses

067.173.855.3
41.3
53.4
64.4
64.5
66.8
69.1
65.6
67.4
59.9
52.9
37.7
46.3
71.6
75.9
74.5
79
70
41.6
26.7
18.3
13.3
11.8
6.6
4.7
3.2
3.1
5
9.9
11

income-statement-row.row.interest-income

002.72.2
2.4
2.2
0
0
0.1
0.1
0
0
0
0
0
0
0.1
0.6
0.4
0.6
470
0
18
0
0.1
0
0
0
0
0
0
0
0

income-statement-row.row.interest-expense

02.42.72.2
2.4
2.2
0.5
-0.1
0.3
-0.5
0.5
0.6
0.2
0.3
0.4
0.1
0.2
-1.9
0.4
0.3
-0.6
0.1
-135
-0.1
0.2
0
5
-0.2
0
0
-0.4
0
0

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-2.7-3.20
1.8
-2.3
-2.7
0.1
-0.3
0.5
-0.4
-0.1
-0.2
-0.1
-0.1
0.2
-2
0.6
-0.1
-0.4
-7
0.3
0.3
0.1
0
0
-5
0.2
0
0
0.4
0
0

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

0000
4.2
0
0
0
-0.3
0.4
0.3
0.4
4.7
0
0
4.1
0
0.8
0.3
-0.1
7.2
-0.1
0
0
0.2
0.1
0.1
0.1
0.1
0.2
0.4
0.6
0.2

income-statement-row.row.total-operating-expenses

0-2.7-3.20
1.8
-2.3
-2.7
0.1
-0.3
0.5
-0.4
-0.1
-0.2
-0.1
-0.1
0.2
-2
0.6
-0.1
-0.4
-7
0.3
0.3
0.1
0
0
-5
0.2
0
0
0.4
0
0

income-statement-row.row.interest-expense

02.42.72.2
2.4
2.2
0.5
-0.1
0.3
-0.5
0.5
0.6
0.2
0.3
0.4
0.1
0.2
-1.9
0.4
0.3
-0.6
0.1
-135
-0.1
0.2
0
5
-0.2
0
0
-0.4
0
0

income-statement-row.row.depreciation-and-amortization

02.80.50.4
4.7
1
0.9
1.2
1
0.9
0.7
0.6
0.5
0.7
1.1
1.4
1.9
1.9
2.3
1.2
0.7
0.4
0.2
0.2
0.2
0.1
0.1
0.1
0.1
0.2
0.4
0.6
0.2

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0-17.9-25.3-16.1
-18.5
-15.6
-20.9
-18
-15
-19.9
-17.9
-11
-2.5
-4
-11.5
-3
-8.8
-9
-4.8
-17
-9.4
7.4
2.5
-0.4
-3.6
-4.7
-5.1
-2.9
-2.5
-1.9
-3.9
-7.5
-5.5

income-statement-row.row.income-before-tax

0-20.6-28.5-16.1
-16.7
-17.9
-21.5
-17.4
-15.2
-20.1
-18.8
-11.6
-2.9
-4.4
-12
-2.8
-9
-7.1
-4.5
-17.2
-8.8
7.7
2.7
-0.3
0
-4.7
-10.1
-2.7
0
0
-3.5
0
0

income-statement-row.row.income-tax-expense

000.10.1
0.1
0
0.1
-0.6
0.2
0.2
0.1
-0.2
0.1
0.1
0.1
0.1
0.1
0.2
0.2
0.3
14.4
-11.4
-0.1
0
0.1
0
5.2
-0.1
0
0.1
-0.8
0
0

income-statement-row.row.net-income

0-20.6-28.6-16.2
-16.8
-17.9
-21.5
-16.9
-15.4
-20.3
-18.9
-11.5
-3.1
-4.5
-12
-3
-9.1
-7.3
-4.7
-17.5
-23.2
19.1
2.6
-0.4
-3.7
-4.8
-10.3
-2.8
-2.5
-2
-3.1
-7.5
-5.5
Sarnased aktsiad
Sind võib huvitada ka:
EW
Edwards Lifesciences Corporation.
87.42 USD
NYSE
SOFW.TA
SofWave Medical Ltd..
1778 ILA
TLV
4549.T
Eiken Chemical Co., Ltd..
2002 JPY
JPX
USAQ
QHSLab, Inc..
0.08685 USD
PNK
QLIFE.ST
Qlife Holding AB (publ).
0.003 SEK
STO
VITR.ST
Vitrolife AB (publ).
178.2 SEK
STO
LFWD
ReWalk Robotics Ltd..
5.16 USD
NASDAQ
BBLG
Bone Biologics Corporation.
1.8001 USD
NASDAQ
300298.SZ
Sinocare Inc..
23.32 CNY
SHZ
HYPR
Hyperfine, Inc..
0.7971 USD
NASDAQ

Korduma kippuv küsimus

Mis on BIOLASE, Inc. (BIOL) koguvara?

BIOLASE, Inc. (BIOL) koguvara on 35101000.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on N/A.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on 0.340.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on -5.081.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on -0.420.

Mis on ettevõtte kogutulu?

Kogutulu on -0.365.

Mis on BIOLASE, Inc. (BIOL) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on -20632000.000.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 17910000.000.

Mis on tegevuskulude arv?

Tegevuskulud on 34661000.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 0.000.